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Genome-wide association studies in canine models
may help locate genomic susceptibility regions that
are relevant to human disease.loci associated with risk for complex diseases, such as auto-
immune disorders, cancer or diabetes. The GWAS ap-Dogs have been called man’s best friend, and for good
reasons. For centuries, humans have domesticated and
trained canines (Canis lupus familiaris) to use both their
intelligence and special abilities for a variety of tasks.
They serve as watchdogs, guide dogs, sled dogs, herding
dogs, sniffing dogs and even Frisbee-catching dogs.
Modern dogs are derived from at least two population
bottlenecks: the first resulting from domestication from
wolves and, very recently, the second from intensive se-
lection deliberately intended to create distinct breeds
with particular morphological features (such as height or
coat color) and behaviors (such as herding or hunting),
frequently suited to particular roles. Consequently, most
breeds are based on a small number of founders, which
in turn results in limited genetic diversity, characterized
by long stretches of linkage disequilibrium [1]. We now
know, however, that intense, artificial inbreeding comes
at a price: genetic susceptibility to a range of auto-
immune diseases, behavioral disorders and cancers,
many mimicking aspects of human diseases [2]. Geneti-
cists have capitalized on this high degree of relatedness
to investigate the genetics of breed-specific diseases that
mimic human disorders.
Initially, the breed structure of dogs enabled geneti-
cists to pinpoint highly penetrant mutations because of
limited locus heterogeneity, akin to studying geographic-
ally isolated human populations, as successfully pursued
in Finland and Iceland. For example, epilepsy [3] and
narcolepsy [4] genes were initially mapped in dogs and
quickly pursued in humans.* Correspondence: chanocks@mail.nih.gov
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reproduction in any medium, provided the orGenome-wide association studies (GWAS) have emerged
as an effective approach to agnostically scan genomes with
dense microarrays of single nucleotide polymorphisms
(SNPs) in search of disease-susceptibility alleles [5]. In par-
ticular, GWAS have transformed the discovery of multiple
proach is predicated on first finding surrogate markers of
susceptibility that are later fine mapped. Eventually, func-
tional variants responsible for disease susceptibility can be
characterized, albeit at a slower pace. In humans, GWAS
have been fruitful for conclusively identifying thousands of
common variants associated with complex diseases. Be-
cause of the complex patterns of human evolution, yielding
smaller blocks of linkage disequilibrium, large sample sizes
(in the thousands) are required for genotyping on arrays
containing hundreds of thousands of SNP markers.
Recent artificial selection of dog breeds has simplified
matters for canine geneticists. Based on the comparison
of whole-genome sequence data for distinct breeds,
Lindblad-Toh et al. [1] predicted that the lack of genetic
heterogeneity in breed structure would simplify GWAS,
reducing the number of cases and controls needed by
orders of magnitude, along with the number of SNP
markers that need to be genotyped. Indeed, many
disease-susceptibility alleles have been identified using
GWAS, sometimes facilitated by using inter-breed re-
latedness to quickly pinpoint the disease-associated
haplotype [2]. Despite the great success of GWAS, some
human diseases remain difficult to study by this ap-
proach because of their relatively low prevalence or high
degree of genomic complexity. Thus, GWAS in canines
can be particularly useful in mapping multigenic traits.Unraveling behavioral problems in dogs
In this issue of Genome Biology, Tang et al. [6] report
the combination of GWAS and targeted sequencing to
map obsessive-compulsive disorder (OCD) in dogs. The
authors [6] cleverly transitioned from GWAS to the judi-
cious use of next-generation sequencing to identify new
OCD alleles. OCD is a common and debilitatingd Central Ltd. The licensee has exclusive rights to distribute this article, in any
ion. After this time, the article is available under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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trusive thoughts and time-consuming repetitive behaviors.
It is the fourth most common psychiatric disorder in
humans, with a lifetime prevalence of approximately 2%.
Twin studies demonstrate a strong genetic component,
and first-degree relatives of an affected individual are at an
increased risk of developing disease. A GWAS conducted
with 1,465 human OCD cases and 400 family trios did
not successfully uncover new disease-susceptibility loci
[7], suggesting a highly complex underlying genetic
architecture.
Canines also present with naturally occurring OCD,
which can manifest as repetition of normal canine be-
haviors. The authors [6] reanalyzed data from an initial
canine GWAS [8]; promising regions of marginal signifi-
cance were then selected for targeted sequencing in
eight OCD dogs and eight controls [6]. In total, 2,291
case-only variants were discovered, of which a subset of
114 were found to be significantly more common in
OCD-risk breeds when genotyped in an independent
sample. Gene-based analyses revealed that cadherin 2
(CDH2), catenin alpha 2 (CTNNA2), ataxin 1 (ATXN1)
and plasma glutamate carboxypeptidase (PGCP) har-
bored the most case-only variants; these initial canine
susceptibility loci, which are all reported to have synap-
tic functions, may also be associated with human OCD.Identifying cancer susceptibility alleles in dogs by
GWAS
Recently in Genome Biology, Karlsson et al. [9] reported
a parallel, multi-breed GWAS approach to study osteo-
sarcoma, a primary bone malignancy that is also ob-
served in children and adolescents. Osteosarcoma is the
most common primary bone malignancy in children and
young adults, affecting approximately four per million
adolescents in the United States each year, with a high
mortality rate in excess of 30%. Peak incidence occurs
during the pubertal growth spurt, and established risk
factors include tall stature and high birth weight. A re-
cent human GWAS of nearly 1,000 osteosarcoma cases
identified regions on 2p25.2 and 6p21.3 that were signifi-
cantly associated with osteosarcoma risk [10]. One locus,
marked by rs7591996 (odds ratio 1.39, 95% confidence
interval 1.23 to 1.54, P = 1.0 × 10-8) at 2p25.2 mapped to
an intergenic region, but the second locus, marked by
rs1906953 at 6p21.3 (odds ratio 1.57, 95% confidence
interval = 1.35 to 1.83, P = 8.0 × 10-9) mapped to intron 7
of a plausible candidate gene, glutamate receptor metab-
otropic 4 (GRM4). GRM4 is involved in intracellular sig-
naling and inhibition of the cyclic AMP signaling
cascade.
Canine osteosarcoma is clinically similar to human
osteosarcoma and has the advantage of being commonamong certain breeds (such as greyhounds, Rottweilers
and Irish wolfhounds). Remarkably, in this study of 309
dogs from three breeds [9], 33 osteosarcoma-associated
loci were discovered that can explain perhaps 50% of
disease variation within each breed. Interestingly, there
was no overlap in regions of association between breeds,
although small sample size and fixation of several risk
haplotypes may have prevented seeing these associations
across breeds. Pathway analyses of human genomic
regions syntenic to the canine GWAS loci revealed
significant connections related to growth, osteoblast dif-
ferentiation and proliferation, and tumor suppression.
Only a fraction of the genes and pathways reported in
the canine GWAS have been previously implicated in
osteosarcoma, further demonstrating the power of ag-
nostic GWAS to uncover novel regions of the genome
in canine models. Although GRM4 was not specifically
replicated in the canine GWAS, another glutamate re-
ceptor gene, GRIK4, was significantly associated in grey-
hounds, and regions near GRM4 reached fixation in
Rottweilers.Confirmation of why dogs are man’s best friends
The successful discovery by GWAS of new susceptibility
alleles for canine osteosarcoma and OCD exemplifies
the value of conducting genetic studies in dogs. It is
notable that in these two instances, there is a striking
similarity in the disease phenotypes between dogs and
humans. One might imagine, therefore, that the canine
findings are likely to replicate in humans and even-
tually translate into new biological insights that could
lead to new strategies for diagnosis, prevention, or
treatment.
Having already applied next-generation sequencing
technologies to solving complex genetic models in
dogs, we can expect to see many more disease loci
mapped by canine geneticists. Furthermore, because of
the artificial inbreeding in dogs, it may be easier to use
SNP microarrays to discover disease-associated struc-
tural and copy-number variations. When these analyt-
ical approaches are optimized in dogs they may, in
turn, be applied to human disease mapping. In this
regard, our furry friends may teach humans new tricks
with old methods.
In summary, genetic insights gained from canine
disease models have the potential to accelerate parallel
discovery in humans and eventually advance the imple-
mentation of precision medicine. GWAS is indeed go-
ing to the dogs, but we should be thankful that our
loyal and devoted companions can offer such rich op-
portunities for discovery. Yes, man’s best friend indeed
has extended a paw to help humans map complex
diseases.
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